01.06.2018
- Swedish drug developer and toll manufacturer Recipharm has set up a dedicated taskforce to manage the potential impact of Brexit on its business. With the deadline for the UK’s...
22.02.2018
- Sweden-based drug developer and toll manufacturer Recipharm has appointed Bernard Pluta to lead its new global development organization, which is to be implemented during the first...
11.04.2017
- Recipharm has appointed Henrik Stenqvist as the company's new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the...
26.08.2016
- Sweden-based drug developer and toll manufacturer Recipharm is investing €3.7 million in expanding its lyophilization capacity at Masate, Italy, near Milan. The company said the...
20.04.2016
- Sweden’s Recipharm has boosted its position in global contract development and manufacturing operations (CDMO) with agreements to buy Kemwell’s businesses in Sweden, the US and...
26.02.2016
- Swedish drug developer and toll manufacturer Recipharm has acquired Italian contract company Mitim for €68 million. The acquisition of the family-owned firm, which is located in...
29.12.2015
- Swedish drug developer and toll manufacturer Recipharm has signed a long-term agreement with Swiss eye-care treatment company Alcon, part of Novartis, to manufacture a range of...
18.11.2015
- Sweden’s Recipharm has agreed to extend a manufacturing and supply agreement for Erdosteine API with Korean drugs firm Daewoong Pharmaceutical. The existing contract has been...
